Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2024 Mar 7;15:1365790. doi: 10.3389/fphar.2024.1365790

Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives

Sicon Mitra 1,, Uttpal Anand 2,, Mimosa Ghorai 3, Balachandar Vellingiri 4, Niraj Kumar Jha 1, Tapan Behl 5, Manoj Kumar 6, Radha 7, Mahipal S Shekhawat 8, Jarosław Proćków 9,*, Abhijit Dey 3,*
PMCID: PMC10955126  PMID: 38515842

In the published article, there was an error in the Affiliation information about Uttpal Anand [2]. Instead of “Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel,” it should be “CytoGene Research & Development LLP, Lucknow, Uttar Pradesh, India.”

As a result of the change in affiliation above, the Conflict of Interest statement must be amended to the following.

Conflict of interest

Author UA was employed by the company CytoGene Research & Development LLP.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES